Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

78.83
BATS BZX Real-Time Price
As of 3:08pm ET
 -0.34 / -0.43%
Today’s Change
68.25
Today|||52-Week Range
131.95
-10.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues872.2M1.1B1.3B1.5B
 
 
 
 
 
Cost of Goods Sold116.5M153.8M190.1M250.1M
 
 
 
 
 
Depreciation And Amortization46.3M86.0M87.9M95.5M
 
 
 
 
 
 
Operating ExpensesGross Income709.4M870.9M1.0B1.2B
 
 
 
 
 
General Expenses1.0B1.1B1.2B1.3B
 
 
 
 
 
Research And Development634.8M661.9M610.8M696.3M
 
 
 
 
 
Total Operating Expenses1.2B1.4B1.5B1.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-322.6M-267.8M-135.1M-158.6M
 
 
 
 
 
Extraordinary Credit33.4M57.2M10.8M5.7M
 
 
 
 
 
Extraordinary Charge-205.9M-603.0M-10.3M-18.5M
 
 
 
 
 
Pre-Tax Equity Earnings-817.0K-538.0K-1.3M-553.0K
 
 
 
 
 
Interest Expense On Debt38.2M39.5M42.7M43.7M
 
 
 
 
 
Other Expenses374.9M15.2M127.9M50.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-154.7M-831.1M-35.9M-142.7M
 
 
 
 
 
Income Taxes-17.1M-200.8M-81.2M-65.5M
 
 
 
 
 
Net Income-171.8M-630.2M-117.0M-77.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS160.0M166.0M174.4M177.1M
 
 
 
 
 
Shares To Calculate EPS Diluted160.0M166.2M174.4M177.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.07-$3.81-$0.67-$0.44
 
 
 
 
 
EPS Diluted-$1.07-$3.81-$0.67-$0.44